open access

Vol 52, No 1 (2021)
Editorial
Submitted: 2021-02-04
Accepted: 2021-02-04
Get Citation

Polish haematology: looking to the future

Wiesław Wiktor Jędrzejczak
DOI: 10.5603/AHP.2021.0002
·
Acta Haematol Pol 2021;52(1):2-3.

open access

Vol 52, No 1 (2021)
EDITORIAL
Submitted: 2021-02-04
Accepted: 2021-02-04

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Polish haematology: looking to the future

Journal

Acta Haematologica Polonica

Issue

Vol 52, No 1 (2021)

Article type

Editorial

Pages

2-3

DOI

10.5603/AHP.2021.0002

Bibliographic record

Acta Haematol Pol 2021;52(1):2-3.

Authors

Wiesław Wiktor Jędrzejczak

References (10)
  1. Giebel S, Basak G, Bieniaszewska M, et al. Current status and progress of Polish hemato-oncology. Acta Haematol Pol. 2021; 52(1): X–X.
  2. Kwiatkowska K, Bogusz J, Dudek-Godeau D, Bielska-Lasota M. Poprawa wyleczalności chorych na niektóre nowotwory złośliwe w Polsce w latach 2000–2009. In: Wojtyniak B, Goryński P. ed. Sytuacja zdrowotna ludności polski i jej uwarunkowania. Narodowy Instytut Zdrowia Publicznego — Państwowy Zakład Higieny, Warszawa 2016: 161–171.
  3. Jedrzejczak WW, Pojda Z. Bone marrow transplantation in Polish conditions. A modified method of marrow collection and preparation for transplantation. Arch Immunol Ther Exp (Warsz). 1987; 35: 79–86.
  4. Ratajczak MZ, Jędrzejczak WW. Elimination of red blood cells from marrow inoculum using centrifugation on a gradient of polysaccharide and ditrizoate prior blood group incompatible bone marrow transplantation (Polish). Pol Tyg Lek. 1987; 42: 907–910.
  5. Jedrzejczak WW, Szczylik C, Pojda Z. Success of bone marrow transplantation in congenital Diamond-Blackfan anemia: a case report. Eur J Haematol. 1987; 38: 204–206.
  6. Jedrzejczak WW, Szczylik C, Matej H, et al. Allogeneic bone marrow transplantation from HLA identical siblings following conditioning with busulphan and cyclophosphamide. First results. Folia Haematol Int Mag Klin Morphol Blutforsch. 1989; 116(3–4): 403–408.
  7. Rejestr przeszczepień komórek krwiotwórczych szpiku, krwi obwodowej oraz krwi pępowinowe. Biuletyn informacyjny. Poltransplant. 2020; 29(1): 42–49.
  8. Wywóz i przywóz do Polski narządów I komórek krwiotwórczych. Biuletyn informacyjny. Poltransplant. 2020; 29(1): 89–92.
  9. Robak T, Jamroziak K, Gora-Tybor J, et al. Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study). J Clin Oncol. 2010; 28(11): 1863–1869.
  10. Holowiecki J, Grosicki S, Giebel S, et al. Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. J Clin Oncol. 2012; 30(20): 2441–2448.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl